UK 12:22 Thursday, 12 November 2026
Breaking news and expert analysis on fast-moving AIM and LSE listed shares
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Previously writing on footwear brand company Dr. Martens (DOCS) earlier this month with the shares at 118p on it “delighted to appoint” a new CFO, I noted good luck to him as I concluded ‘with its half-year results to 30th September therefore not set to be good - and scheduled for 30th of this month - and I questioning second half improvement it is relying on considering also the current consumer environment, I suggest this is currently a what financial position will Giles Wilson be taking on?, £1.15 billion market capitalisation, avoid/sell’. Today the half-year results headlined “Strategic progress despite challenging USA backdrop”… so what of a share price currently down from a 114.8p last close towards 85p?!
Already a member? Sign in
• All premium articles
• Tom Winnifrith’s Bearcast
• Access to all the entire nearly 13 year archive
• ShareProphets Daily Newsletter
Cancel any time
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
